Literature DB >> 17850189

ECVAM's approach to intellectual property rights in the validation of alternative methods.

Jens P Linge1, Thomas Hartung.   

Abstract

In this article, we discuss how intellectual property rights affect the validation of alternative methods at ECVAM. We point out recent cases and summarise relevant EU and OECD documents. Finally, we discuss guidelines for dealing with intellectual property rights during the validation of alternative methods at ECVAM.

Mesh:

Year:  2007        PMID: 17850189     DOI: 10.1177/026119290703500411

Source DB:  PubMed          Journal:  Altern Lab Anim        ISSN: 0261-1929            Impact factor:   1.303


  2 in total

1.  Perspectives on validation of high-throughput assays supporting 21st century toxicity testing.

Authors:  Richard Judson; Robert Kavlock; Matthew Martin; David Reif; Keith Houck; Thomas Knudsen; Ann Richard; Raymond R Tice; Maurice Whelan; Menghang Xia; Ruili Huang; Christopher Austin; George Daston; Thomas Hartung; John R Fowle; William Wooge; Weida Tong; David Dix
Journal:  ALTEX       Date:  2013       Impact factor: 6.043

2.  RE-Place: A Unique Project Collecting Expertise on New Approach Methodologies.

Authors:  Mieke Van Mulders; Nancy Liodo Missigba; Birgit Mertens; Vera Rogiers
Journal:  Front Pharmacol       Date:  2022-06-22       Impact factor: 5.988

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.